SAN DIEGO, Oct. 26 – Amersham Biosciences has agreed to distribute InforMax’s desktop software in Latin America, the companies announced Friday.

In the exclusive distribution agreement, Piscataway, NJ-based Amersham will distribute InforMax’s Vector NTI Suite molecular biology software in Brazil, Argentina, Bolivia, Guyana, Colombia, Peru, Surinam, French Guiana, Chile, Nicaragua, Venezuela, Ecuador, Uruguay, Paraguay, Mexico, Panama, El Salvador, Honduras, Guatemala, Costa Rica, and all Caribbean countries except Cuba. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.